Mass photometry is a label-free bioanalytical technology that enables the characterization of AAV samples in solution by reliably measuring the empty-full AAV ratio using small sample amounts. This method can now be applied to GMP-regulated environments through new software solutions that are compliant with both FDA 21CFR11 and EU Annex 11.
In this webinar, we will explain how the new, compliant software solutions address all regulatory requirements, including user management, audit trails, and signing options when exporting files from Refeyn software applications. The new software solutions will be compatible with the SamuxMP and SamuxMP Auto mass photometers, which are optimized for AAV analytics. This allows the ability to rapidly measure AAV empty/full ratios with high precision and reproducibility for any AAV serotype.
Attend this webinar to enhance your understanding of:
- How to streamline AAV analytics in GMP environments
- How to enable the rapid, accurate, and reproducible analysis of full/empty capsid ratios across all AAV serotypes
- Software requirements to ensure regulatory compliance in both R&D and manufacturing
Cátia Crespo
Director, Product Management & Manager - Sustaining Engineering at Refeyn
Cátia Crespo is a Director of Product Management Software at Refeyn, a company specializing in the development and manufacturing of instrumentation for the characterisation of biomolecules using mass photometry. Prior to joining Refeyn, she worked as a Product Manager for leading companies. Cátia completed her PhD and Post-doc in Prof Elisabeth Knust's laboratory at the Max Planck Institute of Molecular Cell Biology and Genetics (Dresden, Germany), where she carried out multiple research projects in the fields of ophthalmology, developmental biology and genetics.